PSAT1 and Nasu-Hakola disease: Intriguingly, genetic silencing or pharmacological inhibition of PSAT1 in mouse osteoclasts leads to an impairment in osteoclast multinucleation [54], similar to that observed in monocyte-derived osteoclasts of NHD patients [55].